Religrace Parenteral India Private Limited is a pharmaceutical company engaged in the manufacturing and supply of sterile injectable products. Founded in 2021 and headquartered in Dewas, Madhya Pradesh, the company offers a broad range of high-quality formulations including Sodium Chloride And Dextrose Injection IP, Dextrose Injection IP, Ciprofloxacin Injection IP, Multiple Electrolyte And Dextrose Injection and Metronidazole Injection IP Isotonic.
With a focus on innovation, quality, and patient safety, Religrace Parenteral operates a state-of-the-art production facility that complies with Good Manufacturing Practices (GMP). Our commitment to ethical standards and continuous improvement drives us to exceed client expectations while contributing to the broader goal of accessible healthcare. By partnering with hospitals, distributors, and government institutions, we aim to be a trusted name in the Indian pharmaceutical landscape.
Key Facts of Religrace Parentral India Private Limited
|
Nature of Business
|
Manufacturer and Supplier
|
|
Location
|
Dewas, Madhya Pradesh, India
|
|
Year of Establishment
|
2021
|
|
GST Number
|
23AALCR1120J1ZO
|
|
Number of Employees
|
07
|
|
Mode of Transport
|
By Air, Road and Rail
|
|
Mode of Payment
|
Online Payments(NEFT/RTGS/IMPS), Cheque/DD, Wallet & UPI
|
|
| |
|
|
Send Inquiry
